Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display

3882 - Differential clinical and pathological characteristics of hereditary neuroendocrine pancreatic tumours (NEPT)


08 Oct 2016


Poster Display


Gema Marín Zafra


Annals of Oncology (2016) 27 (6): 136-148. 10.1093/annonc/mdw369


G. Marín Zafra1, J. Tebar Masso2, J.M. Rodriguez Gonzalez1, P. Segura Luque1, J.L. Alonso Romero1, T. García3, P. Sanchez Henarejos1, A. Soto1, M.J. Martinez4

Author affiliations

  • 1 Medical Oncology, Hospital Universitario Virgen de la Arrixaca, 30120 - Murcia/ES
  • 2 Endocrinology, Hospital Universitario Virgen de la Arrixaca, 30120 - Murcia/ES
  • 3 Medical Oncology, Hospital Universitario Morales Meseguer, 30008 - Murcia/ES
  • 4 Medical Oncology Unit, Hospital Universitario Santa Lucia, 30120 - Cartagena/ES


Abstract 3882


NEPT include a complex spectrum of neoplasm with diverse biology and clinical course. Multiple Endocrine Neoplasm type 1 (MEN1) syndrome is an autosomal dominant disease associated with a high frequency of duodenal and pancreatic neuroendocrine tumours. Due to its very low prevalence, the biological and clinical behaviour of hereditary NEPT is poorly characterized. Since they are underrepresented in clinical trials, the therapeutic approach is usually extrapolated from sporadic NEPT guidelines. The aim of this work was to define the clinical and pathological characteristics of hereditary NEPT.


We retrospectively analysed a large cohort (1983-2015) of MEN1-associated NEPT, corresponding to all incident cases in a high-prevalence geographical area. Clinical and pathological characteristics of hereditary and sporadic NEPT were compared. Chi-2 test and T-tests were used for comparison of qualitative and quantitative variables. Survival analysis was performed with Kaplan-Meier curves and log-rank test.


A total of 85 patients were included: 58 (68%) patients with sporadic and 27 (31%) with hereditary NEPT (77%: c.1546delC). In comparison with sporadic cases, hereditary NEPT more frequently presented as non-metastatic tumors (96% vs. 36%, p = 0.001), with multiple lesions (74% vs. 25%, p 


Hereditary NEPT associated to MEN1 syndrome exhibit a very good prognosis, with no disease-related deaths observed in a large cohort of patients. Although genetic-driven early diagnose may have contributed to this outcome, the low grade and low proliferation found in our series, suggest a different biological behaviour for hereditary NEPT.

Clinical trial identification

Legal entity responsible for the study

Hospital Universitario Virgen de la Arrixaca, Murcia, Spain




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings